196 related articles for article (PubMed ID: 1828008)
1. Anti-CD3 antibody-induced activated killer cells: cytokines as the additional signals for activation of killer cells in effector phase to mediate slow lysis.
Ting CC; Hargrove ME
Cell Immunol; 1991 Jul; 135(2):273-84. PubMed ID: 1828008
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD3 antibody-induced activated killer cells subsets of killer cells that mediate fast or slow lytic reactions.
Ting CC; Hargrove ME; Henrich P
Immunol Invest; 1990 Aug; 19(4):347-61. PubMed ID: 2145218
[TBL] [Abstract][Full Text] [Related]
3. Role of protein kinase C and cytokines on the function and production of cytolytic granules in alpha CD3-activated killer-cell-mediated killing of tumor cells.
Wu J; Shiver J; Hargrove ME; Ting CC
Int J Cancer; 1993 Apr; 53(6):973-7. PubMed ID: 8473055
[TBL] [Abstract][Full Text] [Related]
4. IL-4 regulation of a protein kinase C independent pathway for the generation of alpha CD3-induced activated killer cells.
Ting CC; Hargrove ME
Cell Immunol; 1992 Mar; 140(1):130-44. PubMed ID: 1531452
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor activity of anti-CD3-induced activated killer cells.
Yun YS; Hargrove ME; Ting CC
Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087
[TBL] [Abstract][Full Text] [Related]
6. IL-4 regulation of perforin gene expression and BLT-esterase production in alpha CD3-induced activated killer cells.
Ting CC; Liang SM; Wang J; Chen YY; Hargrove M; Xu N
Biotechnol Ther; 1994-1995; 5(3-4):99-115. PubMed ID: 8608327
[TBL] [Abstract][Full Text] [Related]
7. Regulation by glutathione of the effect of lymphokines on differentiation of primary activated lymphocytes. Influence of glutathione on cytotoxic activity of CD3-AK-.
Liang SM; Liang CM; Hargrove ME; Ting CC
J Immunol; 1991 Mar; 146(6):1909-13. PubMed ID: 1826013
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
[TBL] [Abstract][Full Text] [Related]
9. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
10. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
11. Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations.
Stanková J; Hoskin DW; Roder JC
Cell Immunol; 1989 Jun; 121(1):13-29. PubMed ID: 2470516
[TBL] [Abstract][Full Text] [Related]
12. Regulation by glutathione of the activation and differentiation of IL-4-dependent activated killer cells.
Hargrove ME; Wang J; Ting CC
Cell Immunol; 1993 Jul; 149(2):433-43. PubMed ID: 8330319
[TBL] [Abstract][Full Text] [Related]
13. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
14. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
Anderson PM; Blazar BR; Bach FH; Ochoa AC
J Immunol; 1989 Feb; 142(4):1383-94. PubMed ID: 2521662
[TBL] [Abstract][Full Text] [Related]
16. Activation of human T cells obtained pre- and post-interleukin-2 (IL-2) therapy by anti-CD3 monoclonal antibody plus IL-2: implications for combined in vivo treatment.
Weil-Hillman G; Schell K; Segal DM; Hank JA; Sosman JA; Sondel PM
J Immunother (1991); 1991 Aug; 10(4):267-77. PubMed ID: 1834166
[TBL] [Abstract][Full Text] [Related]
17. Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.
Damle NK; Doyle LV
Lymphokine Res; 1989; 8(2):85-97. PubMed ID: 2525210
[TBL] [Abstract][Full Text] [Related]
18. Dichotomy of glutathione regulation of the activation of resting and preactivated lymphocytes.
Ting CC; Hargrove ME; Liang SM; Liang CM; Sharrow SO
Cell Immunol; 1992 Jun; 142(1):40-53. PubMed ID: 1534039
[TBL] [Abstract][Full Text] [Related]
19. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
20. CD7 augments T cell proliferation via the interleukin-2 autocrine pathway.
Jung LK; Roy AK; Chakkalath HR
Cell Immunol; 1992 Apr; 141(1):189-99. PubMed ID: 1372842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
